Eagle's Eye View: Your Weekly CV Update From ACC.org

• The PREVENT Equations & Cardiovascular Risk, the CREST-2 Trials on Carotid Disease , Physician Burnout, Food Labeling & CV Health

  In this week's View, Dr. Eagle looks at the use of PREVENT equations to assess cardiovascular (CV) disease risk and the CREST-2 randomized trials that examined stenting versus endarterectomy for asymptomatic carotid disease. He then explores physician burnout and the use of coaching to help treat it.  Finally, Dr. Eagle explores how clearer, "front of package" food labeling in grocery stores can provide consumers with practical, science-based guidance to improve CV health.     Subscribe to Eagle's Eye View    

  --------  

  8:12

  --------

  8:12
• Improving The Culture and Climate Surrounding Cardiology

  In this week's View, Dr. Eagle looks at the potential for electrophysiology (EP) ablation in ambulatory care. He then explores several new studies that reveal the rising rates of heart failure and hypertension. Finally, Dr. Eagle discusses a very important new survey from ACC on the need to improve the professional climate and culture for US cardiologists and trainees.   Subscribe to Eagle's Eye View  

  --------  

  7:28

  --------

  7:28
• Gastrointestinal Bleeding After LAAO, Lifestyle Modification & Metabolic Syndrome, Beta-Blockers & the Treatment of Preserved LVEF

  In this week's View, Dr. Eagle looks at gastrointestinal bleeding (GIB) after left atrial appendage occlusion (LAAO).  He then explores lifestyle modifications to treat metabolic syndrome.  Finally, Dr. Eagle examines a recent study which found that beta-blockers failed to reduce death, myocardial infarction (MI) or heart failure (HF) in patients with preserved left ventricular ejection fraction (LVEF).   Subscribe to Eagle's Eye View  

  --------  

  8:35

  --------

  8:35
• Eagle's Eye View: Highlights from the 2025 AHA Scientific Sessions

  In this week's View, Dr. Eagle highlights several important studies presented at the recent American Heart Association Scientific Sessions. The OCEAN Trial on antithrombotic and stroke prevention in patients with atrial fibrillation (AFib). He then explores VESALIUS-CV, a study on evolocumab versus placebo in patients with atherosclerosis or diabetes and without previous myocardial infarction (MI) or stroke.  Finally, Dr. Eagle discusses the POLY-HF study on the use of a daily polypill that boosts heart function, improves quality of life, and cuts hospitalizations in underserved patients with heart failure with reduced ejection fraction (HFrEF).  Subscribe to Eagle's Eye View  

  --------  

  8:31

  --------

  8:31
• Highlights From 2025 TCT Conference

  In this week's View, Dr. Eagle highlights several trials recently presented at the TCT Conference in San Francisco. The SELUTION DeNovo trial found that use of the sirolimus-eluting balloons with bailout stenting only if necessary was noninferior to routine drug-eluting stent implantation in patients with de novo coronary artery disease. In the ANDES trial, results showed that the use of direct oral anticoagulants after left atrial appendage closure in patients with non-valvular atrial fibrillation was not superior to dual antiplatelet therapy in preventing device-related thrombosis. Finally, Dr. Eagle discusses the PROCTOR study in which percutaneous coronary intervention (PCI) on saphenous vein grafts versus native vessel PCI in post-coronary artery bypass grafting in patients presenting with graft failure.    Subscribe to Eagle's Eye View    

  --------  

  6:10

  --------

  6:10

Mais podcasts de Ensino

Podcasts em tendência em Ensino

Sobre Eagle's Eye View: Your Weekly CV Update From ACC.org

Eagle's Eye View: Your Weekly CV Update From ACC.org: Podcast do grupo